EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,668 Cr | ₹3,210 Cr | ₹3,019 Cr | ₹2,965 Cr | ₹3,408 Cr |
What is the latest Total Current Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,668 Cr |
| Mar2024 | ₹3,210 Cr |
| Mar2023 | ₹3,019 Cr |
| Mar2022 | ₹2,965 Cr |
| Mar2021 | ₹3,408 Cr |
How is Total Current Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,668 Cr | -16.89 | |
| Mar2024 | ₹3,210 Cr | 6.34 | |
| Mar2023 | ₹3,019 Cr | 1.83 | |
| Mar2022 | ₹2,965 Cr | -13.01 | |
| Mar2021 | ₹3,408 Cr | - | |
Compare Total Current Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,231.8 Cr | 1.5% | 4.4% | 33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 1.5% |
4.4% |
33.6% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses